Does low T3 reduce muscle energy production and exercise capacity?

T3 is an important regulator of skeletal-muscle metabolism, but the claim’s downstream implication for low T3 states is more tentative than its mechanistic premise.

Clinical and physiological evidence

• In healthy adults, 3 days of T3 increased vastus-lateralis TCA-cycle flux by ~70%, directly demonstrating increased muscle oxidative metabolism. ATP synthesis did not increase proportionately, however.
• In a double-blind crossover trial of 14 patients with established hypothyroidism, T3 versus T4 treatment did not significantly alter peak VO₂, workload, resting energy expenditure, or exercise tolerance.
• In severe heart failure, low free T3 despite normal TSH/free T4 was associated with lower peak VO₂, lower workload, and poorer ventilatory efficiency; free T3 independently correlated with peak VO₂. This is clinically relevant but observational, so low T3 may also mark illness severity, inflammation, or nutritional compromise rather than directly cause reduced capacity.

Mechanistic evidence

• T3 appears to increase oxidative flux partly at the cost of efficiency: the human ATP-synthesis-to-TCA-flux coupling index fell by about 45%, consistent with mitochondrial uncoupling and thermogenesis.
• In rat oxidative soleus muscle, T3 rapidly activates AMPK, followed by higher PGC-1α expression; longer exposure increases oxygen consumption and oxidative-enzyme activity.
• Mitochondrial p43 thyroid-receptor signaling increases mitochondrial mass, mitochondrial DNA, PGC-1α, and complex-II-supported respiration in mouse muscle. In human primary muscle cells, T3 increases UCP3 mRNA, but did not induce PGC-1α or respiratory-chain genes, underscoring tissue-, fiber-, and species-specific effects.

Bottom line

• T3 convincingly stimulates skeletal-muscle oxidative metabolism and can promote mitochondrial biogenic programs, especially in oxidative muscle. Low T3 could plausibly impair energetics and exercise capacity, but a causal effect in isolated low-T3 states is not established; low T3 alone should not be interpreted as an indication for liothyronine treatment.